Tech Company Financing Transactions

Satori Pharmaceuticals Funding Round

Satori Pharmaceuticals, based in Cambridge, secured $15 million from Polaris Partners and PureTech Ventures.

Transaction Overview

Announced On
5/1/2007
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
281 Albany Street
Cambridge, MA 02139
USA
Email Address
Overview
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.
Profile
Satori Pharmaceuticals LinkedIn Company Profile
Social Media
Satori Pharmaceuticals Company Twitter Account
Company News
Satori Pharmaceuticals News
Facebook
Satori Pharmaceuticals on Facebook
YouTube
Satori Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Ives
  Jeffrey Ives LinkedIn Profile  Jeffrey Ives Twitter Account  Jeffrey Ives News  Jeffrey Ives on Facebook
VP - R & D
Brian Bronk
  Brian Bronk LinkedIn Profile  Brian Bronk Twitter Account  Brian Bronk News  Brian Bronk on Facebook
VP - R & D
Barbara Tate
  Barbara Tate LinkedIn Profile  Barbara Tate Twitter Account  Barbara Tate News  Barbara Tate on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/1/2007: ProVina venture capital transaction
Next: 5/2/2007: SquareOne venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary